NEO
NEOGENOMICS, INC.Marquee-fund ownership over time
This quarter's activity
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates re-entered | Q2 2023 | 13Q | $19 | $8.37 | -57% |
| Renaissance Technologies re-entered | Q3 2024(8Q snapshot) | 7Q | $17 | $8.37 | -49% |
| D.E. Shaw re-entered | Q3 2024(8Q snapshot) | 7Q | $0.00 | $8.37 | — |
| Citadel Advisors | Q4 2024(8Q snapshot) | 6Q | $16 | $8.37 | -47% |
| Millennium Management re-entered | Q4 2024(8Q snapshot) | 6Q | $16 | $8.37 | -47% |
| AQR Capital Management | Q2 2025(8Q snapshot) | 4Q | $7.84 | $8.37 | +7% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Two Sigma Investments | Q1 2026 | Q2 2026 | → $8.24 | -28% |
| Point72 Asset Management | Q3 2024 | Q4 2024 | → $16 | -0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at NEOGENOMICS INC. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 3, 2026 — the most recent Form 4 on file — not from today.
- Form 40001628280-26-040581Jun 3, 2026
- Form 40001628280-26-040579Jun 3, 2026
- Form 40001628280-26-040578Jun 3, 2026
- Form 40001628280-26-040576Jun 3, 2026
- Form 40001628280-26-040574Jun 3, 2026
- Form 40001628280-26-040573Jun 3, 2026
- Form 40001628280-26-040572Jun 3, 2026
- Form 40001628280-26-040571Jun 3, 2026
- Form 40001628280-26-034620May 13, 2026
- Form 40001628280-26-034619May 13, 2026
- Form 40001628280-26-030622May 5, 2026
- Form 40001628280-26-030621May 5, 2026
- Form 40001628280-26-030619May 5, 2026
- Form 40001628280-26-023691Apr 3, 2026
- Form 40001628280-26-023689Apr 3, 2026
Fundamentals
XBRL · NEOGENOMICS, INC.Annual figures sourced directly from NEOGENOMICS, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for NEOGENOMICS INC — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 22, 2026
- 10-QQuarterly reportApr 28, 2026
- 8-KMaterial eventApr 28, 2026
- DEF 14AProxy statementApr 6, 2026
- 10-KAnnual reportFeb 17, 2026
- 8-KMaterial eventFeb 17, 2026
- 8-KMaterial eventJan 12, 2026
- 8-KMaterial eventDec 30, 2025
- 10-QQuarterly reportOct 28, 2025
- 8-KMaterial eventOct 28, 2025
- 8-KMaterial eventAug 8, 2025
- 10-QQuarterly reportJul 29, 2025
- 8-KMaterial eventJul 29, 2025
- 8-KMaterial eventJun 24, 2025
- 8-KMaterial eventMay 27, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Bridgewater Associates | Q2 2026 | open | $8.24 | $10 | +23% |
| Millennium Management | Q2 2026 | open | $0.00 | — | +0% |
| Renaissance Technologies | Q2 2026 | open | $8.36 | $8.37 | +0% |
| Two Sigma Investments | Q1 2026 | Q2 2026 | $11 | $8.24 | -28% |
| D.E. Shaw | Q3 2025 | open | $6.20 | $8.37 | +35% |
| AQR Capital Management | Q2 2025 | open | $7.84 | $8.37 | +7% |
| Citadel Advisors | Q4 2024 | open | $16 | $8.37 | -47% |
| Millennium Management | Q4 2024 | open | $16 | $8.37 | -47% |
| D.E. Shaw | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
| D.E. Shaw | Q3 2024 | Q2 2025 | $16 | $7.84 | -50% |
| Point72 Asset Management | Q3 2024 | Q4 2024 | $16 | $16 | -0% |
| Renaissance Technologies | Q3 2024 | Q4 2024 | $17 | $16 | -1% |
| Bridgewater Associates | Q2 2023 | Q2 2025 | $19 | $7.96 | -59% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.